glp 1 and cancer GLP-1 receptor agonists in the context of cancer: the road ahead JCI - GLP-1 receptor agonists

CA: Writing review & editing, Writing original draft, Validation, Supervision, Methodology, Conceptualization

The study was published in Obesity

States With No Coverage for Obesity-Indicated GLP-1s: In 14 states and the District of Columbia, Medicaid programs do not cover GLP-1s for obesity

Therefore, its imperative to understand what the data tells us about GLP-1 RAs and diabetic retinopathy

(1994) with the possible exception of Phe- 12 (substitution to Ala resulted in 133-fold reduced affinity and 13-fold reduced potency), although the larger Tyr side chain in the Xenopus sequence is likely to be a more acceptable substitution compared with Ala

Vitamin A in Skin and Hair: An Update